Biophytis S.A. (BPTS)
Total Valuation
Biophytis has a market cap or net worth of $7.20 million. The enterprise value is $14.46 million.
Market Cap | 7.20M |
Enterprise Value | 14.46M |
Important Dates
The last earnings date was Tuesday, April 18, 2023, before market open.
Earnings Date | Apr 18, 2023 |
Ex-Dividend Date | n/a |
Share Statistics
Biophytis has 9.74 million shares outstanding. The number of shares has increased by 195.94% in one year.
Shares Outstanding | 9.74M |
Shares Change (YoY) | +195.94% |
Shares Change (QoQ) | +87.34% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.81
Current Ratio | 0.81 |
Quick Ratio | 0.81 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -9.49 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -80.80% |
Return on Capital (ROIC) | -188.08% |
Revenue Per Employee | n/a |
Profits Per Employee | -$827,642 |
Employee Count | 26 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.60% in the last 52 weeks. The beta is 1.24, so Biophytis's price volatility has been higher than the market average.
Beta (1Y) | 1.24 |
52-Week Price Change | -84.60% |
50-Day Moving Average | 0.91 |
200-Day Moving Average | 2.47 |
Relative Strength Index (RSI) | 46.26 |
Average Volume (30 Days) | 1,136,220 |
Short Selling Information
Short Interest | 45,387 |
Short Previous Month | 40,406 |
Short % of Shares Out | 0.47% |
Short % of Float | n/a |
Short Ratio (days to cover) | 1.68 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -19.62M |
Pretax Income | -21.50M |
Net Income | -21.52M |
EBITDA | -18.80M |
EBIT | -19.45M |
Earnings Per Share (EPS) | $860.74 |
Balance Sheet
The company has $6.82 million in cash and $14.08 million in debt, giving a net cash position of -$7.26 million or -$0.75 per share.
Cash & Cash Equivalents | 6.82M |
Total Debt | 14.08M |
Net Cash | -7.26M |
Net Cash Per Share | -$0.75 |
Equity / Book Value | -3.65M |
Book Value Per Share | -0.37 |
Working Capital | -2.94M |
Cash Flow
In the last 12 months, operating cash flow was -$18.59 million and capital expenditures -$229,456, giving a free cash flow of -$18.82 million.
Operating Cash Flow | -18.59M |
Capital Expenditures | -229,456 |
Free Cash Flow | -18.82M |
FCF Per Share | -$5.75 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Biophytis does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Earnings Yield | -298.70% |
FCF Yield | -261.21% |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Buyback Yield | -195.94% |
Shareholder Yield | -195.94% |
Analyst Forecast
The average price target for Biophytis is $15.00, which is 1,927.03% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $15.00 |
Price Target Difference | 1,927.03% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 30, 2023. It was a reverse split with a ratio of 1:10.
Last Split Date | Mar 30, 2023 |
Split Type | Reverse |
Split Ratio | 1:10 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |